Novorapid 100IU/ml Flexpen 3 ml is a rapid-acting human insulin analogue for the treatment of diabetes mellitus in both children (above two years of age) and adults. The active ingredient in Novorapid 100IU/ml Flexpen 3 ml is insulin aspart. Diabetes is a medical condition where your body does not produce enough insulin to control your blood sugar level. Treatment with Novorapid 100IU/ml Flexpen 3 ml helps to prevent complications from your diabetes.
When Novorapid 100IU/ml Flexpen 3 ml is injected, it is extremely fast-acting and works rapidly to normalise blood sugar levels. It typically begins working after 10-20 minutes and will last for between 3 and 5 hours. Due to this short action, Novorapid 100IU/ml Flexpen 3 ml should normally be taken in combination with intermediate-acting or long-acting insulin preparations. Novorapid 100IU/ml Flexpen 3 ml works by ensuring rapid and consistent sugar control. Novorapid 100IU/ml Flexpen 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after food intake. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver.
Your doctor will advise you on how to use Novorapid 100IU/ml Flexpen 3 ml. It should be administered at least 5-10 minutes before the meal or within 20 minutes after you start having a meal. The common side effects of Novorapid 100IU/ml Flexpen 3 ml are hypokalaemia (low potassium), hypoglycaemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itch skin), which may occur at the injection site. Most of these side effects of Novorapid 100IU/ml Flexpen 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Try not to stop taking Novorapid 100IU/ml Flexpen 3 ml of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Do not take Novorapid 100IU/ml Flexpen 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs. Along with Novorapid 100IU/ml Flexpen 3 ml, you should take a healthy diet, exercise regularly, and maintain weight as your doctor advises. Novorapid 100IU/ml Flexpen 3 ml is a cold chain medicine, so it must be stored in the refrigerator between 2-8 degrees Celsius; otherwise, its efficiency might get lost. Do not store it in the freezer of the fridge.
Diabetes (Type 1 diabetes mellitus, Type 2 diabetes mellitus)
Novorapid 100IU/ml Flexpen 3 ml works by ensuring rapid and consistent sugar control. Novorapid 100IU/ml Flexpen 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after the intake of food. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver. Novorapid 100IU/ml Flexpen 3 ml helps in improving the glycaemic control, which in turn decreases the risk of progression of complications of diabetes like damage to the retina (retinopathy), damage to the kidney (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others. Besides this, Novorapid 100IU/ml Flexpen 3 ml can be safely prescribed to the diabetic mother during pregnancy and lactation.
Novorapid 100IU/ml Flexpen 3 ml is for subcutaneous (under the skin) use only and should never be administered intravenously (IV) or in the veins. If you are changing the brand of insulin or if you need to inject your insulin by another method, it should be done under strict medical supervision. Cases of heart failure were reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure. The first symptoms of hyperglycaemia (high blood sugar level) may include symptoms like excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite and acetone odour of the breath. You should closely monitor these symptoms. Symptoms like heart failure, weight gain and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. Novorapid 100IU/ml Flexpen 3 ml may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma and even death. Do not take Novorapid 100IU/ml Flexpen 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs.
Drug-Drug Interactions: Novorapid 100IU/ml Flexpen 3 ml may have an interaction with drugs that may increase the risk of antiarrhythmic (disopyramide), hemorrheologic agents (pentoxifylline), antidiabetic (pramlintide), bleeding disorder drugs (octreotide), antipsychotic (propoxyphene, phenothiazines), female sex hormones (progestogen, oestrogen), thyroid hormones (levothyroxine), anti-asthmatics (albuterol, epinephrine, terbutaline), an antidepressant (fluoxetine, lithium), lipid-lowering pills (reserpine, niacin, clonidine, fenofibrate, guanethidine), pain killers (aspirin), antibiotics (isoniazid), blood sugar enhancing pills (glucagon), male hormone testosterone analogue (danazol), antibiotic (pentamidine).
Drug-Food Interactions: Novorapid 100IU/ml Flexpen 3 ml may interact with an ayurvedic, homoeopathy, Unani, herbal supplements or OTC items. Tell your doctor if you are using these products. Try to avoid intake of alcoholic beverages with Novorapid 100IU/ml Flexpen 3 ml as it may increase or decrease your blood sugar level.
Drug-Disease Interactions: Novorapid 100IU/ml Flexpen 3 ml should not be given to patients with kidney disease, liver disease, low blood sugar/glucose level (hypoglycaemia), and low potassium level (hypokalaemia).
You are recommended not to consume alcohol along with Novorapid 100IU/ml Flexpen 3 ml to avoid unpleasant side-effects. Alcohol may either decrease or increase the blood sugar level which can be fatal.
Novorapid 100IU/ml Flexpen 3 ml can be used during pregnancy. Your insulin dose may need to be changed during pregnancy and after delivery.
Novorapid 100IU/ml Flexpen 3 ml can be given safely to nursing mothers but only under the supervision of a physician.
Drive with caution, Novorapid 100IU/ml Flexpen 3 ml usually causes drowsiness and affects driving ability. Your ability to concentrate and react may be reduced if you have hypoglycaemia (low blood sugar).
Novorapid 100IU/ml Flexpen 3 ml to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor.
Novorapid 100IU/ml Flexpen 3 ml to be taken with caution, especially if you have a history of kidney diseases/conditions. The dose may have to be adjusted by your doctor.
Novorapid 100IU/ml Flexpen 3 ml can be given safely to children provided; dose has to be prescribed by a child specialist.
This item is Not Returnable.
Expires on or after - Sep-23
Diabetes:Â Diabetes is a chronic or lifelong disease that prevents the body from utilizing insulin properly. Insulin is the hormone that controls sugar levels in the blood. Diabetes is a condition in which blood glucose levels are above normal. It is of two types, namely: type-1 and type-2 diabetes. Type-1 diabetes is a condition in which the pancreas produces little or no insulin. Type-2 diabetes affects the way the body processes sugar. Symptoms of diabetes include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, weight loss, and itchy skin.
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.